Weakening German dressings market worries industry
This article was originally published in Clinica
German device suppliers had a difficult time in 1998, according to the federal trade association, BVMed. Aggregated sales of its 161 member companies came to DM6.1 billion ($3.25 billion) - only 4.6% up on the previous year. This fell below the industry's expectations, says BVMed's annual report.
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.